This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
But the coming year will bring challenges affecting patientcare, the industry workforce and their business. Pharmacy professionals are used to overcoming obstacles in this competitive, dynamic field.
Health care practitioners (HCPs), and patients too, are sounding the alarm on unnecessary barriers in the system that can negatively impact patients’ access to quality care according to a new survey of HCPs and patients.
With the appropriate safeguards in place, artificial intelligence has transformative potential to advance clinical research and accelerate medical product development to improve patientcare. Article: Adopting AI for R&D in 2025 what needs to be addressed?
Pharmacies can strategically invest in AI technologies to streamline operations and improve patientcare while addressing cost challenges and maximizing return on investment in 2025.
We are excited to share that the latest Clinical Excellence in Respiratory Care event will take place virtually on 7 May 2025. This free, one-day conference is a must-attend event for healthcare professionals looking to stay informed on the latest clinical advancements in respiratory care.
After yet another record year for health data breaches, updated federal security rules to protect patient information are on the table in 2025. Increased privacy protections, in their view, would impact the financial viability of medical practices — especially small ones — and even timely patientcare.
Discover the key trends and innovations shaping the pharma and life sciences industries in 2025, focusing on efficiency, patientcare, customer experience, and advancements in rare disease treatments.
Judith Alberto, MHA, RPh, BCOP, discusses the COA 2025 Community Oncology Conference, emphasizing its focus on transparency in oncology and the role of data in supporting pharmacists' contributions to patientcare.
Medicares increasing focus on quality metrics in 2025 presents critical challenges for healthcare providers. By leveraging solutions like PharmD Live, providers can navigate these challenges effectively, safeguard revenue and improve patientcare. This underscores the urgency of compliance in subsequent years.
By doing this, they can greatly influence both patientcare and environmental sustainability, re-affirming the crucial role of sustainability in the future of healthcare. Circ Econ Sustainability 2025; March 3. Accessed March 2025]. 11 International Pharmaceutical Federation (FIP).
Jim Dente of Advanced Pharmacy Solutions emphasizes the growing role of automation, artificial intelligence, and patient-centric business models in streamlining operations, improving patientcare, and addressing industry challenges such as staff burnout and medication errors.
The Centers for Medicare & Medicaid Services (CMS) has announced a 2.83% reduction in the Medicare Physician Fee Schedule (PFS) for 2025. This change underscores a continued shift toward value-based care, focusing on improving health outcomes and controlling costs.
Top 5 Pharmacy Cash-Based Revenue Blogs from DiversifyRx in 2024 “ Semaglutide & Tirzepatide Resources for Independent Pharmacies “ This blog provides the resources you need to help your patients using these popular medical weight loss solutions.
As a first step, the PQA Blueprint 2025 was leveraged to shape efforts, and objectives, strategies, and tactics were developed to strategically support success of the MTM initiative. Additional detail on these objectives is provided in the table below. Participation in the group is open to any individual at a PQA member organization.
This initiative is not just reshaping patient outcomesit’s reshaping the entire healthcare ecosystem. What is Chronic Care Management (CCM)? Medicare Chronic Care Management (CCM) offers a structured approach to improve the health and well-being of individuals living with multiple chronic conditions.
A multidisciplinary focus As clinical pharmacy continues to evolve, there is increasing emphasis on how roles and responsibilities enhance patientcare through a multidisciplinary approach, particularly in hospital settings. The integration of pharmacists into specialist care teams is a model she believes should be more widely adopted.
The UK is set to be the first country to introduce a new regulatory framework for innovative products manufactured at or close to the point of patientcare, says the Medicines and Healthcare products Regulatory Agency (MHRA). The agency anticipated that the regulation could become law in Summer 2025.
Transforming Pharmacy PracticeXiFinhaspreviewedfindings from its 2025 Pharmacy Transformation Outlook Survey, which highlights the growing role of pharmacists and the increasing interest in achieving operational efficiency through new technology and expanding pharmacy offerings via value-based care and specialty pharmacy.
Each focuses on providing health care quality experience to diverse individuals from diverse disciplines. PQA is now accepting applications for our student and professional programs for 2025-2026. She addressed working with health plans on new programs and services that create patient impact. Learn more.
What greater way to be able to affect patientcare than face to face using a pharmacist who's able to assess, coordinate, and provide service to these patients? Save the date to join us at the 2025 PQA Annual Meeting, May 19-21, at the JW Marriott Tampa Water Street in Tampa, Fla. Learn more.
RPS members will be able to vote on the proposed changes via a ‘special resolution vote’ (SRV) between 13 and 24 March 2025. To vote, pharmacists must be a full RPS member by Friday 28 February 2025.
28, 2025, the FDA announced the approval of Ozempic for reducing the risk of worsening kidney disease and cardiovascular death in adults with chronic kidney disease and Type 2 diabetes. In addition, these agents also decreased the incidence of major cardiovascular events, including heart attacks and strokes, by 13%.
Cost highlighted progress towards completion of PQA’s strategic plan, Blueprint PQA 2025. The 2024 PQA Annual Report documents our progress towards the plan’s goals. “Goal two of our strategic plan is to advance the quality of pharmacist-provided care and services that optimize medication use, adherence and safety.
are wrapping up year four of Blueprint PQA 2025, PQAs five-year strategic plan. This two-year project will begin in early 2025. That work will continue in 2025. Thanks to the support of our members, we will expand this program in 2025. As wenearthe end of 2024,itsagreattimeto reflect on our accomplishments.We
Taking place on 21 November, this one-day respiratory event for the multidisciplinary team brings together renowned experts from recognised Centres of Excellence and other UK and EU hospitals to share their experiences of clinical innovations, examples of best practice and how they are improving patientcare.
As a first step, the PQA Blueprint 2025 was leveraged to shape efforts, and objectives, strategies, and tactics were developed to strategically support success of the MTM initiative. Additional detail on these objectives is provided in the table below. Participation in the group is open to any individual at a PQA member organization.
We also highlight our members' perspectives on the pharmacists' patientcare process, the Southern California wildfire response, and the future of community pharmacy. The registration link is in theMember Resources Library.
The inaugural sustainability newsletter will be circulated on Tuesday, 18 February 2025, so sign up now to receive this as well as future newsletter bulletins and clinical round-ups. The post Hospital Pharmacy Europe announces sustainability content zone and newsletter appeared first on Hospital Pharmacy Europe.
The inaugural sustainability newsletter will be circulated on Tuesday, 18 February 2025, so sign up now to receive this as well as future newsletter bulletins and clinical round-ups. The post Hospital Pharmacy Europe announces sustainability content zone and newsletter appeared first on Hospital Pharmacy Europe.
WASHINGTON, February 18, 2025 PharmD Live , an innovative pharmacist-led virtual care solution powered by AI-driven algorithms, announces the release of its recent white paper, Maximizing Shared Savings for Payviders: ACOs, IDNs, At-Risk Provider Groups and Clinics.
We continue to play a central role in driving meaningful improvements and positive changes related to medication safety, adherence and appropriate use.The 2023 PQA Annual Report documents our progress towards Blueprint PQA 2025. There are still numerous opportunities to be involved with PQA and impact quality medication use in 2023.
Growing environmental concerns about this issue highlight the need for more sustainable prescribing practices that minimise environmental harm while ensuring effective patientcare. 2025 Jan 20;15(1):e088066. Medications contribute substantially to pharmaceutical pollution , impacting both ecological health and public safety.
During the fellowship, individuals will expand their skills and experience in project management, quality measure design and implementation, non-profit administration and association management, and health care quality research. The application window for the 2025-26 fellow cycle will open in September.
The guideline presents opportunities for enhancing patientcare and outcomes through greater shared decision-making conversations and improving asthma awareness while addressing concerns and illness beliefs but this may extend consultation time. 2 National Institute for Health and Care Excellence. Accessed February 2025].
Others warn of relentless mandatory overtime, unrealistic metrics, and a corporate culture that prioritizes numbers over patientcare. Theyre expanding Affordable Care Act coverage into 139 new counties across four states, further entrenching themselves as a dominant force in healthcare. Mandatory OT year-round.
The global market for AI-based software is projected to be $126 billion by 2025, up from $10.1 The continued adoption of AI and ML will shape the future of the pharmaceutical industry, leading to enhanced efficiency, better patientcare, and cost savings. [1] 2] AI and ML driven change will impact numerous industries.
The government has also set an objective of eliminating any delays to procedures of 18 months or more by April next year, and over 65 weeks by March 2024, and reducing all waits to less than a year by 2025. billion) to ease the backlog in NHS care, including £1 billion to get routine surgeries back on track. billion ($7.5
This article explores top strategies that can help you lead with confidence and achieve executive success in 2025. These tools provide accessible, personalized support, reinforcing a patient-first mindset. For executives, this isnt just a marketing strategy; its a way to align your brand with the values patientscare about most.
My SynBioBeta panel discussion was about the shape of biopharma in 2025 – a seemingly futuristic time that’s now less than four years away. Despite the rapid advances seen with synthetic biology, to expect widespread change in pharma’s approach to it in such a short time is unlikely. Funding radical innovation.
UKCPA priorities As the newly appointed chair of UKCPA , taking up this post in January 2025, John has set three key priorities for his three-year term. That means being open to new ways of working, upskilling in emerging fields like pharmacogenomics, and finding innovative ways to support patientcare.
Members actively engage and interact with peers and PQA leadership to advance PQA Blueprint 2025. PQA Convenes premiered in 2022 to bring national health care leaders together to build consensus and develop plans of action to address opportunities for improving patientcare and outcomes in key focus areas for PQA.
Reliance on high-volume products imported from overseas can make patientcare vulnerable to global supply shocks and these plans to support UK manufacturing will limit this impact. What’s more, single-use devices substantially contribute to the 156,000 tonnes of clinical waste that the NHS produces every year in England.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content